DaBomb Protein Biotech Valuation
Is 6578 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 6578 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 6578 (NT$18.9) is trading above our estimate of fair value (NT$3.84)
Significantly Below Fair Value: 6578 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6578?
Key metric: As 6578 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 6578's PS Ratio? | |
|---|---|
| PS Ratio | 3.5x |
| Sales | NT$356.75m |
| Market Cap | NT$1.24b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.3x |
| Enterprise Value/EBITDA | 75.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 6578's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3x | ||
4732 NatureWise Biotech & Medicals | 5.7x | n/a | NT$1.3b |
3205 Sagittarius Life Science | 2.5x | n/a | NT$1.1b |
7782 Speeding Rocket | 1.4x | n/a | NT$861.8m |
6242 Li Kang Biomedical | 2.4x | n/a | NT$1.4b |
6578 DaBomb Protein Biotech | 3.5x | n/a | NT$1.2b |
Price-To-Sales vs Peers: 6578 is expensive based on its Price-To-Sales Ratio (3.5x) compared to the peer average (3x).
Price to Sales Ratio vs Industry
How does 6578's PS Ratio compare vs other companies in the TW Personal Products Industry?
| 1 Company | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
4136 Thai Ho Group | 0.4x | n/a | US$10.79m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: 6578 is expensive based on its Price-To-Sales Ratio (3.5x) compared to the Asian Personal Products industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is 6578's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.5x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 6578's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.